Pharmacoeconomic comparison of ziprasidone with other atypical oral antipsychotic agents in schizophrenia. (2011). Farmeconomia. Health Economics and Therapeutic Pathways, 12(1), 29-40. https://doi.org/10.7175/fe.v12i1.96